Evaluation of HS-CRP and lipid profile in COPD

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 5, 2013, Pages 801-803

  Nillawar, Anup N ^a   Joshi, Kedar B ^b   Patil, Sandip Bharat ^c   Bardapurkar, Jayshree S ^d   Bardapurkar, Suhas J ^e  

^a Baroda Medical College   (India)

^b GMC   (India)

^c Chirayu Medical College and Hospital   (India)

^d SIMS   (India)

^e Shree Nursing Home ^*  (India)

Author keywords

COPD; HS CRP; Lipid profile; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVE C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIPID ANALYSIS; PATIENT ASSESSMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 84877102624     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5187.2943     Document Type: Article

References (13)

1. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. The Indian journal of chest diseases & allied sciences [Internet]. 2005;48 (1):23-29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16482948.
2. GOLD criterion [Internet]. 2011 [cited 2012 Sep 4]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
3. van Eeden SF, Yeung A, Quinlam K, Hogg JC. Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society [Internet]. 2005 Jan [cited 2012 Apr 29];2(1):61-67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16113470.
4. Nillawar A, Bardapurkar S, Bardapurkar J. High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease. Lung India [Internet]. 2012 [cited 2012 Jan 30];29 (1):2-4. Available from: http://www.lungindia.com/text.asp?2012/29/1/24/92358.
5. Rogerio Rufino JR, Lapa Silva. cellualr and biochemical bases of Chronic obstructive pulmonary Disease. J Bras Pneumol. 2006;32 (3):241-48.
6. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. The European Respiratory Journal: official journal of the European Society for Clinical Respiratory Physiology [Internet]. 2008 Oct [cited 2012 Aug 15];32 (4):962-999. Available from: http://www.ncbi. nlm.nih.gov/pubmed/18579551.
7. Ulubafl B. Lipid Profile in Patients with Chronic Obstructive Pulmonary Disease. 2003;4 (3):120-22.
8. Article O, Dadapeer K. Lipoprotein Profile in Patients with Chronic Obstructive Pulmonary Disease in a Tertiary Care Hospital in South India. 2011;5 (5):990-93.
9. The TORCH Study Group. The TORCH (TOwards a Revolution in COPD Health) survival study protocol. European Respiratory Journal [Internet]. 2004 Aug 1 [cited 2012 Sep 4];24 (2):206-10. Available from: http://erj.ersjournals.com/cgi/content/abstract/24/2/206
10. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. (Carlton, Vic.) [Internet]. 2007 Sep [cited 2012 Sep 3];12 (5):634-641. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/17875049.
11. Man SFP, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. Creactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax [Internet]. BMJ Group; 2006;61 (10):849-853. Available from: http://www.pubmedcentral.nih.gov/articlerender.fc gi?artid=2104755&tool=pmcentrez&rendertype=abstract.
12. Ridker PM. High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease. Circulation [Internet]. 2001 Apr 3 [cited 2012 Oct 17]; 103 (13):1813-8. Available from: http://circ.ahajournals.org/content/103/13/1813.full.
13. th ed. Burtis CA, Ashwood ER BD, editor. St. Louis, MO: Elsevier Saunders; 2004.